Driven by patients,
guided by science
The Anticancer Fund supports scientific research and outstanding care for cancer patients.
We are a Belgian non-profit organisation with an international scope. We depend fully on donations and private funding to finance our work.
OUR PROMISE
-
We invest in the most promising research to make measurable progress in the fight against cancer. -
We strive to improve survival and quality of life, financial return is not within the scope of our activities. -
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need. -
We seek impact and we invest our resources where we believe we can make the most progress. -
Every cancer deserves the same attention, regardless of prevalence or profitability.
In the news
WE MAKE A DIFFERENCE
-
We invest in research
We put science to work for patients and we strive for short-term, meaningful impacts where they are most needed. -
We set up clinical trials
We are an independent, non-profit intermediary and focus on clinical research with limited economic value. -
We connect people
As we are just a small part of the enormous cancer research ecosystem, we don't act alone. -
We advise professionals
According to our mission and vision, we provide free advice in designing trials and reviewing scientific research. -
We help cancer patients
We personally answer therapy-related questions from patients and provide non-judgmental information.
Our current focus areas
-
Drug repurposing
Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
-
Less common and rare cancers
We don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
-
Combination therapies
It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination...
-
Preventing tumour recurrence
For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...